ZYMVOL raises €3 million in a financing round to boost enzyme discovery and development

by Parc Científic de Barcelona

Since its founding in 2017, ZYMVOL has established itself as a leader in computational enzyme discovery and design. The company collaborates with the R&D teams of some of the world’s largest compani...

Read more

New study looks at how mRNAs change during atherosclerosis progression

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP) have studied variations in the length of mRNAs during the progression of ...

Read more

Massive Data Analysis Advances the Understanding of How Immunotherapy Works

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature Communications.

Read more

Investigadores del IMIBIC identifican inflamación sistémica en vitíligo y posibles nuevas vías terapéuticas para esta enfermedad

by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

Personal investigador del Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) y el Hospital Universitario Reina Sofía (HURS), ha identificado, por primera vez, la existencia de pa...

Read more

Investigadores identifican una nueva variante genética responsable de una deficiencia severa de coenzima Q

by Fundación Andaluza para la Divulgación de la Innovación y el Conocimiento

Un grupo de investigación del Centro Andaluz de Biología del Desarrollo descubre una variante en el gen COQ4 que afecta la producción de energía celular. El estudio se centra en el caso de una pac...

Read more

Los organoides cerebrales: minicerebros para avanzar en la investigación del Alzheimer

by Fundación Pasqual Maragall

Estos “minicerebros”, creados a partir de células madre que permiten simular el desarrollo de la enfermedad de Alzheimer y explorar en detalle los factores que contribuyen a su aparición y progr...

Read more

Un estudio colaborativo internacional, coordinado por personal investigador de Biogipuzkoa, alerta sobre diferencias en la supervivencia de pacientes con Colangiocarcinoma relacionadas con aspectos étnicos

by Biodonostia

El estudio observacional internacional de pacientes con Colangiocarcinoma (CCA) más exhaustivo realizado hasta la fecha en Latinoamérica, coordinado por personal investigador del Instituto de Invest...

Read more

Revelado un mecanismo clave para controlar la actividad que regula la identidad neuronal

by CSIC - Centro Superior de Investigaciones Científicas

Un equipo del Instituto de Neurociencias (CSIC-UMH) descubre que un factor esencial para la identidad neuronal se regula por un proceso llamado ‘splicing’

Read more

A study reveals that exosomes are surrogate markers of metabolic alterations of the brain in Alzheimer’s disease

by CIC bioGUNE

The study, published in the Journal of Extracellular Vesicles, analyzes the metabolic profiles of brain tissue and extracellular vesicles obtained from those tissues in Alzheimer’s patients, uncover...

Read more

Sixteen I3PT research projects receive €2,6 million in public competitive calls

by Instituto de Investigación e Innovación Parc Taulí

The Parc Taulí Research and Innovation Institute (I3PT) has obtained a total of 2.604.000 Euros in competitive funding to develop sixteen health research and innovation projects

Read more

New biomarkers are defined that demonstrate how the Hepatitis B and D viruses interact

by Fundació Clínic per a la Recerca Biomèdica

The study focused on the detection of two HBV markers: Hepatitis B core-related antigen and HBV RNA. These two markers are detectable in the blood and reflect the activity of a unique viral DNA called...

Read more

Integra Therapeutics, first company to move into Advanced Therapies Platform at SJD Barcelona Children's Hospital

by Integra Therapeutics

Integra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology diseases and gene therapies for rare diseases. The company recently announced a...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Researchers Discover How Acute Myeloid L...

by Institut de Recerca Sant Pau

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it a...

Photos Stream